Steven Cohen Biocryst Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

$51 Billion
Q3 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 238,187 shares of BCRX stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

238,187

Holding current value

$1.69 Million

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$7.55 - $9.06 $1.8 Million - $2.16 Million	238,187 New	238,187 $1.81 Million
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $7.9 Million - $12.4 Million	1,616,244 New	1,616,244 $8.21 Million
Q3 2023 Nov 14, 2023	SELL	$6.71 - $7.92 $8.36 Million - $9.87 Million	-1,245,887 Reduced 31.11%	2,758,813 $19.5 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $27.5 Million - $34.8 Million	3,951,200 Added 7385.42%	4,004,700 $28.2 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $15.4 Million - $22.9 Million	-1,935,127 Reduced 97.31%	53,500 $446,000

Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $20.9 Million - $28.2 Million	1,988,627 New	1,988,627 $22.8 Million
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $5.08 Million - $11.5 Million	644,100 New	644,100 $6.82 Million
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $292,144 - $499,374	-25,272 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $2 Million - $2.76 Million	-178,641 Reduced 87.61%	25,272 $350,000
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $2.9 Million - $3.6 Million	203,913 New	203,913 $2.93 Million
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $23.8 Million - $44 Million	-3,230,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.37 - $8.61 $8.76 Million - $22.4 Million	2,598,200 Added 410.72%	3,230,800 $24.1 Million
Q3 2020 Nov 16, 2020	SELL	$3.43 - $5.53 $874,547 - $1.41 Million	-254,970 Reduced 28.73%	632,600 $2.17 Million
Q2 2020 Aug 14, 2020	SELL	$1.9 - $5.61 $4.05 Million - $12 Million	-2,130,562 Reduced 70.59%	887,570 $4.23 Million
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $8.58 Million - $22 Million	-5,364,768 Reduced 64.0%	3,018,132 $6.04 Million
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $8.15 Million - $17.7 Million	5,122,900 Added 157.14%	8,382,900 $28.9 Million
Q3 2019 Nov 15, 2019	BUY	$2.5 - $3.73 $8.15 Million - $12.2 Million	3,260,000 New	3,260,000 $9.34 Million
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $138,088 - $434,194	-47,453 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.38 - $9.72 $2.23 Million - $2.94 Million	-302,547 Reduced 86.44%	47,453 $386,000
Q4 2018 Feb 14, 2019	BUY	$6.51 - $9.6 $2.28 Million - $3.36 Million	350,000 New	350,000 $2.83 Million
Q1 2018 May 15, 2018	SELL	$4.35 - $5.82 $4.06 Million - $5.43 Million	-933,766 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.16 - $5.33 $3.88 Million - $4.98 Million	933,766	933,766 $4.59 Million

Others Institutions Holding BCRX

# of Institutions

310

Shares Held

200M

Call Options Held

640K

Put Options Held

507K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.32B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account